Cargando…
Targeted therapy in pulmonary veno-occlusive disease: time for a rethink?
BACKGROUND: Pulmonary veno-occlusive disease (PVOD) is a rare condition with poor prognosis, and lung transplantation is recommended as the only curative therapy. The role of pulmonary arterial hypertension targeted therapy in PVOD remains controversial, and long-term effects of targeted therapy hav...
Autores principales: | Luo, Qin, Jin, Qi, Zhao, Zhihui, Zhao, Qing, Yu, Xue, Yan, Lu, Zhang, Yi, Xiong, Changming, Liu, Zhihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924010/ https://www.ncbi.nlm.nih.gov/pubmed/31856792 http://dx.doi.org/10.1186/s12890-019-1031-3 |
Ejemplares similares
-
Pulmonary veno‐occlusive disease with vanished pulmonary consolidation
por: Yamasaki, Kei, et al.
Publicado: (2023) -
Improved hemodynamics and cardiopulmonary function in patients with inoperable chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty
por: Jin, Qi, et al.
Publicado: (2019) -
Mitomycin induced pulmonary veno-occlusive disease
por: Kunadu, Afua, et al.
Publicado: (2021) -
Genetic cause of pulmonary veno-occlusive disease
por: Mohite, Kaustubh, et al.
Publicado: (2022) -
Exercise feature and predictor of prognosis in patients with pulmonary artery stenosis‐associated pulmonary hypertension
por: Li, Xin, et al.
Publicado: (2022)